Since both CHKA expression and TNM stage are independent predictors of poor outcome for CRC patients (Table 2), we further evaluated whether the CHKA/TNM stage combination model could provide better prognostic accuracy than single-parameter model. The gene discussed is CHKA; the disease is colorectal carcinoma.